| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 51.877 | 62.401 | 58.473 | 61.325 | 74.359 | 69.408 | 58.455 | 137.626 | 134.892 |
| Total Income - EUR | - | 51.877 | 62.401 | 58.473 | 61.325 | 74.359 | 69.408 | 58.455 | 141.175 | 135.175 |
| Total Expenses - EUR | - | 9.815 | 18.068 | 14.814 | 13.955 | 15.799 | 13.039 | 21.302 | 44.956 | 33.728 |
| Gross Profit/Loss - EUR | - | 42.062 | 44.334 | 43.659 | 47.370 | 58.560 | 56.369 | 37.153 | 96.219 | 101.447 |
| Net Profit/Loss - EUR | - | 40.505 | 42.462 | 41.905 | 45.530 | 56.487 | 54.347 | 36.621 | 95.177 | 97.473 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 2 |
Check the financial reports for the company - Neuroimag S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.311 | 4.218 | 7.172 | 4.415 | 2.158 | 3.602 | 2.428 | 2.663 | 1.830 |
| Current Assets | - | 39.737 | 48.005 | 43.635 | 50.939 | 64.241 | 60.268 | 44.669 | 112.731 | 138.187 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.704 | 4.093 | 2.914 | 10.831 | 6.851 | 3.581 | 6.204 | 95.122 | 1 |
| Cash | - | 36.033 | 43.912 | 40.721 | 40.108 | 57.390 | 56.687 | 38.466 | 17.609 | 138.187 |
| Shareholders Funds | - | 40.550 | 50.146 | 50.301 | 54.819 | 65.611 | 63.270 | 45.571 | 104.220 | 97.521 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 498 | 2.077 | 505 | 536 | 788 | 600 | 1.526 | 11.174 | 42.496 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuroimag S.r.l.